BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 31937331)

  • 1. Aberrant DNA methylation profile exacerbates inflammation and neurodegeneration in multiple sclerosis patients.
    Celarain N; Tomas-Roig J
    J Neuroinflammation; 2020 Jan; 17(1):21. PubMed ID: 31937331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.
    Hauser SL; Oksenberg JR
    Neuron; 2006 Oct; 52(1):61-76. PubMed ID: 17015227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Deoxyribonucleic Acid Methylation Contribute to the Pathophysiology of Multiple Sclerosis.
    Celarain N; Tomas-Roig J
    Front Genet; 2019; 10():1138. PubMed ID: 31798633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Genetic and Epigenetic Basis of Multiple Sclerosis.
    Hojati Z
    Adv Exp Med Biol; 2017; 958():65-90. PubMed ID: 28093709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics in Multiple Sclerosis.
    Chan VS
    Adv Exp Med Biol; 2020; 1253():309-374. PubMed ID: 32445101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Methylation: a New Player in Multiple Sclerosis.
    Li X; Xiao B; Chen XS
    Mol Neurobiol; 2017 Aug; 54(6):4049-4059. PubMed ID: 27314687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics of multiple sclerosis: an updated review.
    Küçükali Cİ; Kürtüncü M; Çoban A; Çebi M; Tüzün E
    Neuromolecular Med; 2015 Jun; 17(2):83-96. PubMed ID: 24652042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Modifications and Therapy in Multiple Sclerosis.
    Aslani S; Jafari N; Javan MR; Karami J; Ahmadi M; Jafarnejad M
    Neuromolecular Med; 2017 Mar; 19(1):11-23. PubMed ID: 27382982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics in Multiple Sclerosis: Molecular Mechanisms and Dietary Intervention.
    Rito Y; Torre-Villalvazo I; Flores J; Rivas V; Corona T
    Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):8-15. PubMed ID: 26915659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential role of epigenetic modifications in the heritability of multiple sclerosis.
    Zhou Y; Simpson S; Holloway AF; Charlesworth J; van der Mei I; Taylor BV
    Mult Scler; 2014 Feb; 20(2):135-40. PubMed ID: 24493701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic changes in neurology: DNA methylation in multiple sclerosis.
    Iridoy Zulet M; Pulido Fontes L; Ayuso Blanco T; Lacruz Bescos F; Mendioroz Iriarte M
    Neurologia; 2017 Sep; 32(7):463-468. PubMed ID: 25976949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation, demyelination, and degeneration - recent insights from MS pathology.
    Stadelmann C; Wegner C; Brück W
    Biochim Biophys Acta; 2011 Feb; 1812(2):275-82. PubMed ID: 20637864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [DNA Methylation Profile of CD14+ Monocytes Changes in Primary Progressive Multiple Sclerosis].
    Kiselev IS; Kulakova OG; Baturina OA; Kabilov MR; Boyko AN; Favorova OO
    Mol Biol (Mosk); 2023; 57(5):819-826. PubMed ID: 37752647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Updated Review of Epigenetic-Related Mechanisms and their Contribution to Multiple Sclerosis Disease.
    Eslahi M; Nematbakhsh N; Dastmalchi N; Teimourian S; Safaralizadeh R
    CNS Neurol Disord Drug Targets; 2023; 22(3):381-393. PubMed ID: 35043771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic research in multiple sclerosis: progress, challenges, and opportunities.
    Zheleznyakova GY; Piket E; Marabita F; Pahlevan Kakhki M; Ewing E; Ruhrmann S; Needhamsen M; Jagodic M; Kular L
    Physiol Genomics; 2017 Sep; 49(9):447-461. PubMed ID: 28754822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.
    Dulamea AO
    Adv Exp Med Biol; 2017; 958():91-127. PubMed ID: 28093710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tale of histone modifications and its role in multiple sclerosis.
    He H; Hu Z; Xiao H; Zhou F; Yang B
    Hum Genomics; 2018 Jun; 12(1):31. PubMed ID: 29933755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and degeneration in multiple sclerosis.
    Brück W; Stadelmann C
    Neurol Sci; 2003 Dec; 24 Suppl 5():S265-7. PubMed ID: 14652785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Sclerosis Pathology.
    Lassmann H
    Cold Spring Harb Perspect Med; 2018 Mar; 8(3):. PubMed ID: 29358320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic insights into multiple sclerosis disease progression.
    Kular L; Jagodic M
    J Intern Med; 2020 Jul; 288(1):82-102. PubMed ID: 32614160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.